Reaction
Application Site Infection reporting signals
As of the last recalculation, Application Site Infection appears in 506 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is GLYCERIN, LIDOCAINE (PRR 103.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Glycerin, Lidocaine | 33 | 103.6 | 103.9 |
| Docosanol | 33 | 99.0 | 99.2 |
| Minoxidil Foam 5% (Womens) | 16 | 20.6 | 20.6 |
| Minoxidil | 20 | 19.0 | 19.0 |
| Crisaborole | 4 | 17.3 | 17.3 |
| Buprenorphine | 28 | 13.1 | 13.1 |